Aspen Pharmacare Price to Book Ratio 2017-2025 | APNHY
Historical price to book ratio values for Aspen Pharmacare (APNHY) over the last 10 years. The current price to book ratio for Aspen Pharmacare as of September 17, 2026 is 0.00.
| Aspen Pharmacare Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-16 | 9.52 | 0.00 | |
| 2025-06-30 | 6.58 | 0.00 | |
| 2024-12-31 | 8.55 | 0.00 | |
| 2024-06-30 | 12.27 | 0.00 | |
| 2023-12-31 | 10.69 | 0.00 | |
| 2023-06-30 | 9.15 | 0.00 | |
| 2022-12-31 | 7.54 | 0.00 | |
| 2022-06-30 | 7.80 | 0.00 | |
| 2021-12-31 | 12.93 | 0.00 | |
| 2021-06-30 | 10.32 | 0.00 | |
| 2020-12-31 | 7.76 | 0.00 | |
| 2020-06-30 | 7.51 | 0.00 | |
| 2019-06-30 | 6.47 | 0.00 | |
| 2018-12-31 | 8.52 | 0.00 | |
| 2018-06-30 | 16.80 | 0.00 | |
| 2017-12-31 | 19.98 | 0.00 | |
| 2017-06-30 | 19.35 | 0.00 | |
| 2016-12-31 | 18.31 | 0.00 | |
| 2016-06-30 | 21.77 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $4.248B | $2.065B |
| Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $44.899B | 17.67 |
| BridgeBio Pharma (BBIO) | United States | $13.352B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $9.749B | 24.85 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.409B | 20.18 |
| Bausch Health Cos (BHC) | Canada | $2.129B | 1.33 |
| Personalis (PSNL) | United States | $1.687B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.652B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.019B | 9.58 |
| Assembly Biosciences (ASMB) | United States | $0.519B | 24.98 |
| Sol-Gel Technologies (SLGL) | Israel | $0.178B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.043B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |